V

VA Long Beach Healthcare System | Tibor Rubin VA Medical Center

Research site
(Unclaimed)
Location
5901 East 7th Street, Long Beach, California, United States of America
Site insights

Top conditions

Hepatitis (13 trials)

Hepatitis A (10 trials)

Hepatitis C (10 trials)

Non-Small-Cell Lung Carcinoma (9 trials)

Lung Cancer (9 trials)

Top treatments

Peginterferon
Daclatasvir
Ribavirin
Telaprevir
Cisplatin
Prednisone
Pemetrexed Disodium
Relamorelin
Ramelteon
Talazoparib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 90
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW)

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 dia...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

This study consists of two periods. The objective of Period 1 is to evaluate the efficacy of upadacitinib in combination with a 26-week corticosteroi...

Active, not recruiting
Giant Cell Arteritis (GCA)
Drug: Upadacitinib
Other: Placebo

The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access

Active, not recruiting
Vascular Access
Hemodialysis
Procedure: Arteriovenous fistula (AVF)
Biological: Human Acellular Vessel (HAV)

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy...

Active, not recruiting
Ulcerative Colitis
Drug: Filgotinib
Drug: Placebo

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...

Active, not recruiting
Prostate Cancer
Drug: Placebo plus enzalutamide
Drug: talazoparib plus enzalutamide

This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of tal...

Active, not recruiting
mCRPC
Drug: Talazoparib with enzalutamide
Drug: Placebo with enzalutamide

Trial sponsors

S

Southern California Institute for Research and Education (17 trials)

National Cancer Institute (NCI) logo

National Cancer Institute (NCI) (10 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems